OXYMETAZOLINE HYDROCHLORIDE
| Brand name | RHOFADE |
|---|---|
| Active ingredient | OXYMETAZOLINE HYDROCHLORIDE |
| Strength | 1% |
| Dosage form | CREAM |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | January 2017 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12350255 | June 2035 | use U-3494 |
| 9974773 | June 2035 | use U-2306 |
| 10751325 | June 2035 | use U-2921 |
| 10335391 | June 2035 | use U-2567 |
| 11517560 | June 2035 | use U-3494 |
| 8883838 | December 2031 | product |
| 7812049 | May 2028 | use U-1959 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.